InterValve's Series B Round

InterValve raised a round of funding on August 14, 2014. Investors include RiverVest Venture Partners.

InterValve is developing an aortic valvuloplasty balloon for treatment of calcific aortic stenosis. Calcific aortic stenosis is the most common cause of acquired valvular heart disease in the Western …

Articles about InterValve's Series B Round: